To confirm that our microRNA was differentially expressed in breast cancer and acts as a tumor suppressor through regulation of the ErbB/PI3K pathway, TCGA cohort, and multiple GSE dataset analysis were performed accompanied by target prediction software and CLIPseq data analysis. This evidence concerns the gene EGFR and breast carcinoma.